NCT01004016
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +8 more
- Locations
-
- Japan Japan
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
8,970 public trials
1,744 recruiting studies
Neurodegenerative Diseases trial results
NCT00322153
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Forest Investigative Site 010 Phoenix, Arizona, United States
- Forest Investigative Site 062 Costa Mesa, California, United States
- Forest Investigative Site 050 Fresno, California, United States
- Forest Investigative Site 024 San Francisco, California, United States
Completed
R(+)PPX High Dose Treatment of ALS
NCT00600873
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- University of Virginia Charlottesville, Virginia, United States
NCT00407095
- Conditions
- Advanced Stage Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +7 more
- Locations
-
- S308.3.007 Site # 220 La Jolla, California, United States
- S308.3.007 Site # 211 San Francisco, California, United States
- S308.3.007 Site # 214 Fort Lauderdale, Florida, United States
- S308.3.007 Site # 218 Gainsville, Florida, United States
NCT00437125
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Genova, Italy
Completed
Project TAP: Tailored Activities Project
NCT00259467
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Behavior, +9 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT01187966
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
Not specified
Completed
Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-Administered
NCT00966966
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Pfizer Investigational Site Utrecht, Netherlands
NCT00392912
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +10 more
- Locations
-
- Michael E. DeBakey VA Medical Center Houston, Texas, United States
NCT00666445
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +12 more
- Locations
-
- Veterans Affairs Medical Center (Brain Science Center) Minneapolis, Minnesota, United States
- Veterans Affairs Medical Center (Geriatric Research, Education and Clinical Center) Minneapolis, Minnesota, United States
- Noran Neurology Clinic Plymouth, Minnesota, United States